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Background: Inflammation is a key factor in the pathogenesis of respiratory diseases. Early life exposure to
microbial agents may have an effect on the development of the immune system and on respiratory health later in
life.
In the present work we aimed to evaluate the associations between early life microbial exposures, and fractional
exhaled nitric oxide (FeNO) at school age.
Methods: Endotoxin, extracellular polysaccharides (EPS) and β(1,3)-D-glucan were measured in living room dust
collected at 2–3 months of age in homes of participants of three prospective European birth cohorts (LISA, n = 182;
PIAMA, n = 244; and INMA, n = 355). Home dampness and pet ownership were periodically reported by the parents
through questionnaires. FeNO was measured at age 8 for PIAMA and at age 10/11 for LISA and INMA.
Cohort-specific associations between the indoor microbial exposures and FeNO were evaluated using multivariable
regression analyses. Estimates were combined using random-effects meta-analyses.
Results: FeNO at school age was lower in children exposed to endotoxin at age 2–3 months (β -0.05, 95%
confidence interval (CI) -0.10;-0.01) and in children with reported dog ownership during the first two years of life
(GM ratio 0.82, CI 0.70-0.96). FeNO was not significantly associated with early life exposure to EPS, β(1,3)-D-glucan,
indoor dampness and cat ownership.
Conclusion: Early life exposure to bacterial endotoxin and early life dog ownership are associated with lower FeNO
at school age. Further studies are needed to confirm our results and to unravel the underlying mechanisms and
possible clinical relevance of this finding.
Keywords: Fractional exhaled nitric oxide, Endotoxin, Extracellular polysaccharides, β(1,3)-D-glucan, Pets, Dampness,
Indoor, Children, Cohort studyBackground
The first years of life may be a crucial period for the devel-
opment of the immune system and the onset of allergic
and respiratory disorders [1,2]. In the last decade, numer-
ous studies assessed associations between measured micro-
bial agents and related indoor factors and reported* Correspondence: lcasas@creal.cat
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reproduction in any medium, provided the orrespiratory and allergic outcomes in children [3-13]. Only
few studies measured early-life microbial exposures and in-
vestigated health effects prospectively. They found that ex-
posure to high levels of endotoxin in the first months of life
may reduce the risk of eczema in infancy [7]. However,
findings regarding wheezing and asthma are inconsistent
[5,6,14]. Regarding indoor factors associated with higher in-
door microbial agents levels, previous studies observed that
early life exposure to indoor mould and dampness increases
the risk of asthma [15-17]. However, the direction of the as-
sociations between early life exposure to pet ownership andtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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found that the presence of a dog in the home during early
life attenuated TNF-α production [18] and had a protective
effect on atopy and wheezing [19,20]. Other studies ob-
served positive or non-significant associations between
home exposure to cats or dogs and atopy, respiratory symp-
toms and asthma [21-24]. In addition, a systematic review
suggested no association with dog ownership with large
heterogeneity across studies [25].
Inflammation is a key factor in the pathogenesis of re-
spiratory diseases and FeNO is considered to be a non-
invasive biomarker that is associated with eosinophilic
airway inflammation [26-28]. High levels of NO in the
airways are associated with asthma and other respiratory
disorders [29] and with respiratory symptoms and atopy
in children [30-33]. In epidemiological studies, using
FeNO has the advantage that it is a continuous and eas-
ily measureable variable, as well as an objective variable,
in contrast to self-reported categorical variables. Several
epidemiologic studies showed associations between en-
vironmental exposures such as air pollution [34,35],
polycyclic aromatic hydrocarbons [36], indoor allergens
[37] and other indoor factors [38] and FeNO. However,
the effects of early life exposure to microbial agents and
indoor factors on FeNO have not been explored. In our
study, we assessed the associations of microbial agents
(endotoxin, EPS and β(1,3)-D-glucans) in house dust, re-
ported dampness and pet ownership early in life with
FeNO in school-aged children in three European birth
cohorts participating in the European HITEA project
(Health Effects of Indoor Pollutants: Integrating micro-
bial, toxicological and epidemiological approaches).
Methods
Study population and design: description of the three
birth cohorts
As part of the European HITEA project, the present study
includes information from three ongoing European birth
cohorts that started between 1996 and 1999: LISA (influ-
ence of life-style factors on the development of the immune
system and allergies in East and West Germany) in
Germany [39], PIAMA (Prevention and Incidence of
Asthma and Mite Allergy) in the Netherlands [40]. and
INMA (INfancia y Medio Ambiente [Environment and
Childhood]) in Spain [41]. Written informed consent was
obtained from all parents and the studies were approved by
the local ethics committees in each cohort region: the
Ethik-Kommission der Bayerischen Landesärztekammer for
LISA, the Centrale Commissie Mensgebonden Onderzoek
(CCMO), the Medisch Ethische Commissies of the Univer-
sity Medical Center Utrecht, the Erasmus Medical Center
Rotterdam, and the Academisch Ziekenhuis Groningen for
PIAMA and the Ethics Committee of the Institut Munici-
pal d’Investigació Mèdica – Parc de Salut Mar for INMA.A description of the participating birth cohorts is given in
the Additional file 1 and in the paper describing the expo-
sures under study [42]. The present study includes children
with measured endotoxin, EPS and/or β(1,3)-D-glucans in
living room dust collected during early life and FeNO mea-
surements at school age (182 from LISA, 244 from
PIAMA, and 355 from INMA).
Fractional exhaled Nitric Oxide (FeNO)
FeNO was measured in LISA at 10 years of age, in
PIAMA at 8 years of age [43] and in INMA at 10 to
13 years of age, according to the American Thoracic So-
ciety guidelines [44] using the NIOX MINO® in LISA
and INMA and the NIOX analyser (Aerocrine, Solna,
Sweden; http://www.aerocrine.com) in PIAMA. In LISA
and INMA children were refrained from eating or drink-
ing one hour before the measurement. They were asked
to inhale to near-total lung capacity through the NIOX
MINO®, and to exhale immediately at a constant flow
rate of 50 mL/sec until a NO plateau of at least 3 seconds
could be identified during an exhalation of at least 6 seconds.
Measurements in both cohorts were performed until a
correct FENO measurement was displayed. If necessary,
the FENO test was repeated to obtain one acceptable
measurement.
In PIAMA, children were instructed to inhale to near-
total lung capacity through a NO scrubber (Dräger com-
bination filter, Dräger, Lübeck, Germany), integrated in
the NIOX analyzer, and to exhale immediately at a con-
stant flow rate of 50 mL/second, until a NO plateau of
at least 2 seconds could be identified during an exhal-
ation of at least 4 seconds. A maximum of 6 attempts
were performed to obtain three acceptable FENO mea-
surements. FENO in PIAMA is expressed as the average
of the 3 measurements.
In the LISA cohort children who had taken any anti-
asthmatic or anti-inflamatory medication did not per-
form the test. In PIAMA and INMA the use of anti-
asthmatic medication (in the past 24 hours in INMA, in
the past 48 hours in PIAMA) or anti-inflammatory
medication (in the past 24 hours for INMA and PIAMA)
was recorded. Four children in PIAMA and 49 in INMA
had taken anti-asthmatic or anti-inflammatory medica-
tion. In the three birth cohorts, all values were above the
LOD. Children did not have any active upper or lower
respiratory tract viral infection on the day of the
measurement.
Dust collection, extraction and analyses
Living room dust samples were collected at the child’s
age of 2–3 months in the homes of the participants,
using vacuum cleaners equipped with ALK filterholders
containing a paper filter and the date of sampling was
recorded. Samples were collected on living room floors
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Collected samples were stored at −20°C, and analyzed
for microbial agents at in the Institute for Risk Assess-
ment Sciences (IRAS, Utrecht, NL). Endotoxin has been
determined with the Limulus Amebocyte Lysate test and
glucan and EPS with specific enzyme immunoassays as
in previous house dust analyses [45]. Levels were
expressed in Endotoxin Units (EU), EPS Units (EPSU),
and μg of β(1,3)-D-glucan per mL, with as lower limit of
detection (LOD) 10 EU/mL (2 EU/mL in INMA), 180
EPSU/mL, and 2 μg/mL, respectively, and converted into
concentrations in the original dust samples (in EU/mg,
EPSU/mg and μg/mg). Samples with non-detectable
amounts of endotoxin, glucans and EPS were assigned a
value of 2/3 of the LOD. Detailed information on the
dust collection, extraction and analyses and a description
of the values below the LOD is shown elsewhere [42].
Reported indoor factors: dampness at home and cat and
dog ownership
Questions about housing characteristics and potential
exposures in the home environment were taken from
questionnaires administered to the parents from birth to
the child’s age of 8 (PIAMA) and 10 years (LISA and
INMA). Dampness or visible mould at home was re-
ported by the parents at the child’s ages of 3 months, 1
and 2 years in the three cohorts. We combined these
data into a single binary exposure variable on ever re-
ported dampness or visible mould during the first 2 years
of life. Cat and dog ownership was reported at birth and
at the child’s ages of 1, 2, 4, 6 and 10 (8 in PIAMA) years
in the three cohorts. For the statistical analyses, we com-
puted separate 3-category variables for cat and for dog,
describing the timing of the first cat/dog ownership.
These variables indicated “Never” (no report of owner-
ship), “Ever during the first 2 years of life” (at least one
report of ownership in the first 2 years of life), and “Ever
after the first 2 years of life, but not during the first
2 years of life” (at least one report of ownership after the
first 2 years of life, but no report during the first 2 years)
exposure.
Potential confounders and effect modifiers
The questionnaires administered during pregnancy or at
birth and at the child’s ages of 1, 2, 4, 6 and 10 (8 in
PIAMA) years included socio-demographic, health and
environmental data such as: parental education (low,
medium or high); medical data of the parents; parental
smoking; housing characteristics including the location
of the home (area population density) and moving to an-
other home. Information about the child’s allergic and
respiratory health was obtained from parental reports of
hay fever, rhinitis, eczema, wheezing, asthma medication
and doctor diagnosed asthma. Two new variables, onefor asthma and another including reported allergies,
were computed and considered as potential effect modi-
fiers. Asthma cases were children with a positive answer
to two out of three of the following questions: doctor di-
agnosed asthma; wheezing; asthma medication, in any
year between 4 and10 (8 in PIAMA) years of age. Allergy
cases were defined as children with at least one positive
answer to questions on hay fever, rhinitis and eczema in
any year between 4 and 10 (8 in PIAMA) years of age.
Atopy was assessed in 74% of the study population. Spe-
cific immunoglobulin E (sIgE) was measured in blood in
the three cohorts at different time points: 10 years of
age in LISA, 8 years of age in PIAMA and 4 years of age
in INMA. In LISA, atopy was defined as sIgE of at least
0.35 kU/l for 'sx1 inhalant mixture’ (timothy, rye, mug-
wort, house dust mite (Dermatophagoides pteronyssinus,
Der p), cat, dog and mould mixture). In PIAMA, atopy
was defined as sIgE of at least 0.35 kU/l for house dust
mite (Der p), cat, dog, birch, Alternaria alternata and
Dactylis glomerata. Finally, atopy in INMA was defined
as sIgE ≥0.35U/mL of IgE for Der p, cat or grass/pollen.
A list of all the potential confounders evaluated in this
study is provided in the Additional file 1.
Statistical analyses
The distribution of the FeNO, endotoxin, EPS and glu-
can measurements was right-skewed and therefore their
levels were natural log-transformed. Generalized additive
models (GAM) [46] were used to assess the functional
relationship between the concentrations of microbial
agents and FeNO stratified per cohort and in cohort-
adjusted pooled analyses. With descriptive purposes, we
computed quartiles of endotoxin concentrations and ter-
tiles of EPS and glucan concentrations and added a <
LOD category that included samples with microbial
agents measurements below the limit of detection. These
variables were calculated to show the distribution of
FeNO according to the levels of microbial agents. A de-
scription of the quantiles is shown in Table E1 of the
Additional file 1. Nevertheless, the main analyses are
conducted using the microbial agents concentrations as
continuous variables.
To assess the adjusted associations between FeNO and
the exposure variables by cohort, we performed multivari-
able linear regression models. Potential confounders were
a-priori identified from the literature and selected based on
their relationship with FeNO and the exposure variables in
the present study (listed in the Additional file 1). The con-
centration of each microbial agent (endotoxin, EPS and glu-
cans) and target indoor factor (dampness and cat and dog
ownership) was included separately in the models. In order
to facilitate interpretation, the resulting regression coeffi-
cients for categorical variables were back-transformed to
their exponential (exp(β)), yielding the ratio of the GM of
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For continuous natural log-transformed variables, we
present the coefficients (β) in the tables. To facilitate the in-
terpretation of these coefficients in the text, we transformed
the coefficients to (2β-1)*100. This transformation allows
interpreting the coefficient as the percentage of increase in
FeNO when doubling the dose of each microbial agent. In
order to assess the possibility of effect modification of stud-
ied associations with the report of allergy and atopy, we in-
cluded interaction terms between the report of allergy and
atopy and the exposure variables and we performed
stratified analyses. For additional sensitivity analyses, we ex-
cluded individuals that had taken anti-asthmatic or anti-
inflammatory medication during the 48 or 24 hours prior
to the FeNO measurement.
Finally, we performed random-effects meta-analyses in-
cluding the three cohort-specific estimates. We obtained
combined GM ratios and their CI for each microbial agentTable 1 Description of the HITEA project participants, not inc
LISA
Not included
n = 213
Population characteristics
Sex (female): n(%) 104 (48.8)
Age at FeNO measurement (years): mean (sd) -
FeNO (ppb): GM (Gsd) -
Asthma (4 to 10 years old*): n (%) 9 (8.9)
Atopy (sIgE ≥0.35U/mL)a: n (%) 8 (53.3)
Reported allergies (4 to 10 years old*): n (%)bd 50 (39.4)
Parental education: n (%)d
Secondary school 38 (18.4)
Higher than secondary school 159 (76.8)
Parental asthma: n (%) 25 (12.3)
Parental smoking at the age of 10 years*: n (%) 9 (8.7)
Indoor exposures
Endotoxin concentrations (EU/mg): GM (Gsd) 22.6 (2.5)
EPS concentrations (U/mg): GM (Gsd) 46.6 (2.5)
Glucan concentrations (ug/mg): GM (Gsd) 1.9 (1.7)
Dampness at home (first 2 years of life)c 74 (35.1)
Cat ownership: n (%)c
Ever during the first 2 years of life 25 (20.2)
Ever after the first 2 years of life 17 (13.7)
Dog ownership: n (%)bcd
Ever during the first 2 years of life 16 (13.5)
Ever after the first 2 years of life 16 (13.5)
sd: standard deviation; GM: geometric mean; Gsd: geometric standard deviation; Fe
hay fever.
*8 years in PIAMA; aLISA n not included = 15 and n included = 168, PIAMA n not includ
bp-value < 0.05 of the difference between included and not included in LISA; cp-
dp-value < 0.05 of the difference between included and not included in INMA.and indoor factor. Potential heterogeneity between cohorts
was examined using the Cochran Q statistics (p-value <
0.05). Data analysis was conducted with STATA SE 10.0
statistical software (Stata Corporation, College Station, TX,
USA).
Results
A description of the socio-demographic, respiratory
health and indoor exposure characteristics of the HITEA
participants included and not included in this study is
shown in Table 1. Children included were not different
from those not included regarding most characteristics.
Across the participating cohorts, we observed statisti-
cally significant differences for all variables except sex
and doctor diagnosed asthma. Higher parental education
was observed in the LISA cohort, higher asthma preva-
lence in PIAMA and higher smoking report in INMA
compared to the other cohorts. The percentage ofluded and included in the study
PIAMA INMA
Included Not included Included Not included Included
n = 182 n = 309 n = 244 n = 126 n = 355
76 (41.8) 139 (45) 127 (52.1) 57 (45.2) 177 (49.9)
10.2 (0.2) - 8.0 (0.3) - 11.5 (0.7)
14.7 (2.0) - 10.2 (2.0) - 12.4 (2.3)
10 (6.1) 20 (14.5) 19 (10.6) 33 (10.3) 41 (10.8)
80 (47.6) 45 (43.3) 71 (36.8) 7 (14.3) 36 (16.1)
46 (27.1) 64 (41.6) 86 (39.8) 41 (51.3) 117 (33.9)
20 (11.4) 98 (37.3) 80 (33.3) 38 (31.7) 130 (38.4)
148 (84.6) 131 (49.8) 140 (58.3) 12 (10.0) 67 (19.8)
21 (11.9) 93 (30.8) 84 (35.0) 17 (14.1) 34 (9.6)
11 (6.4) 9 (6.1) 10 (5.0) 28 (45.2) 115 (35.8)
23.5 (2.4) 23.2 (3.7) 20.6 (3.2) 4.0 (6.3) 3.1 (6.4)
48.4 (2.1) 29.1 (2.8) 32.9 (3.5) 119.9 (2.7) 116.4 (2.5)
2.0 (1.7) 1.6 (2.1) 1.8 (2.4) - -
62 (34.3) 159 (64.9) 121 (54.8) 72 (57.6) 221 (63.3)
23 (13.8) 79 (42) 59 (27.2) 15 (20.3) 68 (19.3)
26 (15.6) 12 (6.4) 19 (8.8) 10 (13.5) 30 (8.5)
8 (5.0) 51 (28.5) 31 (14.5) 45 (47.9) 143 (40.9)
16 (10.1) 32 (17.9) 16 (7.5) 19 (20.2) 45 (12.9)
NO: fractional exhaled nitric oxide; Reported allergies: eczema, rhinitis or
ed = 104 and n included = 193, INMA n not included = 49 and n included = 224;
value < 0.05 of the difference between included and not included in PIAMA;
Table 2 Description of the FeNO (ppb) according to the
asthmatic status and exposure per cohort
LISA PIAMA INMA
n = 182 n = 244 n = 355
GM (Gsd) GM (Gsd) GM (Gsd)
Asthma
No 13.7 (1.9) 10.4 (1.9) 11.3 (2.1)
Yes 30.3 (2.3) 13.4 (2.0) 27.3 (3.0)
Endotoxin concentrations (EU/mg)
Q1 (<3.54 EU/mg) 12.6 (1.4) 7.8 (1.5) 12.3 (2.4)
Q2 (>3.54-12.4 EU/mg) 17.2 (1.9) 11.5 (2.2) 13.0 (2.2)
Q3 (>12.4-30.6 EU/mg) 14.3 (2.0) 10.1 (1.9) 11.8 (2.1)
Q4 (>30.6 EU/mg) 14.4 (2.0) 9.7 (1.8) 11.5 (2.2)
EPS concentrations (U/mg)
<LOD 14.2 (2.3) 9.5 (2.0) 10.4 (1.8)
T1 (<42 U/mg) 15.2 (2.0) 10.6 (2.0) 11.8 (2.3)
T2 (>42-101 U/mg) 13.8 (1.9) 9.9 (1.9) 12.1 (2.1)
T3 (>101 U/mg) 16.2 (2.2) 12.5 (1.8) 13.2 (2.4)
Glucan concentrations (ug/mg)
<LOD - 9.4 (2.1) -
T1 (<1.55 μg/mg) 15.8 (2.0) 10.9 (1.9) -
T2 (>1.55-2.35 μg/mg) 13.6 (1.9) 10.3 (1.9) -
T3 (>2.35 μg/mg) 15.4 (2.1) 10.7 (1.8) -
Dampness at home
Never 14.9 (2.0) 10.7 (1.9) 12.9 (2.3)
Ever during the first 2 years
of life
14.3 (2.1) 10.0 (2.0) 12.1 (2.3)
Cat ownership
Never 15.5 (2.0) 10.6 (1.9) 12.7 (2.3)
Ever during the first 2 years
of life
16.1 (2.1) 9.7 (1.8) 10.8 (2.2)
Ever after the first 2 years of life 11.4 (1.7) 9.9 (2.4) 15.1 (2.5)
Dog ownership
Never 15.1 (2.0) 10.5 (2.0) 13.3 (2.4)
Ever during the first 2 years
of life
13.4 (1.6) 9.0 (1.8) 11.6 (2.3)
Ever after the first 2 years of life 15.5 (1.6) 10.9 (2.1) 12.3 (2.1)
GM: geometric mean; Gsd: geometric standard deviation; Q: quartile; T: tertile;
EPS: extracellular polysaccharides; <LOD: below the limit of detection.
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cohort whereas the age at FeNO measurement and
FeNO was lower, the percentage of children with atopy
was higher in LISA, where children were older at the mo-
ment of sIgE measurements (10 years old). Regarding the
exposure variables, in INMA, endotoxin concentrations
were lower and the prevalence of dampness and dog own-
ership in the first two years of life was higher. Cat owner-
ship in the first two years of life was higher in PIAMA.
Geometric means of FeNO were lower in individuals
classified in the highest endotoxin quartile in INMA,
FeNO was lower in the mid tertile of EPS in LISA and
INMA and similar trends were observed for glucans in
LISA. Children exposed to cats and to dogs in the first
two years had lower FeNO, except for cats exposure in
LISA. However the differences were not statistically sig-
nificant (p-values ≥ 0.05) (Table 2).
Sex, age at FeNO measurement, asthma, reported al-
lergies, indoor smoking and parental education were as-
sociated with FeNO after mutual adjustment (p-values <
0.05) and thus included in the multivariate models. Par-
ental education was also associated with the levels of in-
door microbial agents, asthma and indoor smoking with
pet ownership, and indoor smoking was additionally as-
sociated with reported dampness.
The smoothed association between FeNO and the micro-
bial agents concentrations, per cohort and combined,
showed that the associations were linear (p-values > 0.05 in
all cases, Figure 1). The combined random-effects adjusted
coefficients for microbial agents concentrations were statisti-
cally significant for endotoxin, showing a 3.7% decrease in
FeNO when doubling the dose of endotoxin (β=−0.05; 95%
CI:-0.10; -0.01). In addition, combined random-effects ad-
justed GM ratios of FeNO were lower for individuals with
reported dog ownership during the first 2 years of life. Asso-
ciation estimates for EPS, glucan, dampness and cat owner-
ship were not statistically significant (p-values ≥ 0.05).
P-values for heterogeneity were above 0.1 in all cases
(Table 3). These associations were adjusted for sex, age
at FeNO measurement, asthma, parental indoor smoking
at the time of the FeNO measurement, and parental edu-
cation. Models including microbial agents measurements
were additionally adjusted for season of dust sampling.
Additional adjustment for other potential confounders
such as season of FeNO measurement, asthma or anti-
inflammatory medication prior to the FeNO measure-
ment, outdoor NO2 at school age or ever moving to
another home did not modify the effect estimates. Add-
itional adjustment for atopy resulted in an attenuation of
the effects. Also, the effect estimates for endotoxin and
early life pet ownership became statistically non-
significant. The effect estimates for endotoxin and early
life dog ownership after these additional adjustments are
shown in Table E2 in the Additional file 1.The association estimates obtained for each exposure
variable were homogeneous across cohorts (heterogeneity
p-values ≥ 0.05). Stratification by parental report of child al-
lergy did not show significant differences (see Table E3 in
the Additional file 1). Moreover, adjusted GM ratios for the
non-asthmatic population (Table E4 in the Additional file 1)
were similar to those presented in Table 3. Finally, the ex-
clusion of individuals who had taken anti-asthmatic or
anti-inflammatory medication in the 48 or 24 hours previ-
ous to the FeNO measurement did not modify our results.
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Figure 1 Smoothed association between natural-log-transformed FeNO coefficients and natural-log-transformed microbial agents
concentrations by cohort and pooled. Adjusted for sex, age of FeNO measurement, asthma, reported allergies (hay fever, rhinitis or eczema),
parental smoking at the moment of the FeNO measurement, parental education and season of dust sampling. The Combined graphs were
additionally adjusted for cohort.
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Higher endotoxin concentrations and presence of dogs
in the home during early life were associated with lower
FeNO at school age. We investigated the association of
FeNO as a potential biomarker of eosinophilic airway in-
flammation and microbial exposure variables, independ-
ently of any association with asthma or atopy. Our
results do not suggest association with disease, but per-
tain to potential long-term effects of early life exposures
on the immune system. Experimental animal studies
previously showed that endotoxin and allergen exposure
during pregnancy may modulate airway inflammation in
offspring later in life, resulting in reduced allergen-
induced immune and airway responses [47,48].
We observed that endotoxin exposure levels and dog
ownership early in life were associated with lower FeNO.
No associations were found for EPS and glucan expos-
ure, cat ownership and reported home dampness. This is
in line with previous epidemiological studies focusing onthe health effects of residential exposure to microbial
agents and pets in children, evaluating associations with
respiratory symptoms, asthma and atopy. Most previous
studies reported that endotoxin may protect against
allergen sensitization, atopic eczema, wheezing and
asthma later in life [6,7,49,50]. Regarding the exposure
to fungal agents such as EPS or glucans, our study did
not find statistically significant associations with FeNO.
These results are in line with those obtained in previous
studies on the association of EPS and glucan levels with
respiratory symptoms [6,21]. However, previous studies
have reported increased risks of asthma during child-
hood in association with mould exposure [15-17]. In our
study, we did not find an association between early life
reports of home dampness and FeNO at school age. The
lack of associations in our study could be explained by
the fact that our exposure was parental-reported damp-
ness and not objective observation. However, results on
previous studies regarding early life exposure to dogs are
Table 3 FeNO adjusted associations with natural-log-transformed microbial agent concentrations, reported home dampness and pet ownership
Combined (random effects)
LISA PIAMA INMA Total Not reported allergies Reported allergies
β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Microbial agents concentrations
Endotoxin (log(EU/mg)) 0.01 (−0.11; 0.13) −0.08 (−0.17; 0.01) −0.06 (−0.11; 0.00) −0.05 (−0.10; −0.01) −0.06 (−0.11; −0.01) −0.06 (−0.14; 0.03)
EPS (log(U/mg)) −0.03 (−0.16; 0.11) 0.02 (−0.07; 0.11) 0.06 (−0.05; 0.17) 0.02 (−0.04; 0.08) 0.07 (0.00; 0.15) 0.08 (−0.05; 0.20)
Glucan (log(μg/mg)) −0.07 (−0.28; 0.15) 0.02 (−0.10; 0.13) - 0.00 (−0.10; 0.10) 0.00 (−0.21; 0.21) 0.04 (−0.15; 0.24)
GM ratio (95%CI) GM ratio (95%CI) GM ratio (95%CI) GM ratio (95%CI) GM ratio (95%CI) GM ratio (95%CI)
Dampness at home
Never 1 1 1 1 1 1
Ever during the first 2 years of life 1.01 (0.80-1.26) 0.89 (0.73-1.1) 1.03 (0.85-1.24) 0.97 (0.87-1.10) 0.93 (0.81-1.06) 1.14 (0.8-1.63)
Cat ownership
Never 1 1 1 1 1 1
Ever during the first 2 years of life 0.97 (0.71-1.33) 0.89 (0.70-1.13) 0.83 (0.65-1.06) 0.89 (0.76-1.03) 0.98 (0.78-1.22) 0.72 (0.51-1.04)
Ever after the first 2 years of life 0.87 (0.64-1.19) 0.96 (0.65-1.43) 1.22 (0.88-1.69) 1.01 (0.82-1.24) 1.11 (0.90-1.37) 0.83 (0.52-1.32)
Dog ownership
Never 1 1 1 1 1 1
Ever during the first 2 years of life 1.04 (0.65-1.68) 0.89 (0.66-1.20) 0.75 (0.62-0.92) 0.82 (0.70-0.96) 0.88 (0.74-1.04) 0.69 (0.51-0.94)
Ever after the first 2 years of life 0.83 (0.57-1.21) 1.18 (0.80-1.76) 1.00 (0.75-1.33) 0.99 (0.81-1.21) 1.02 (0.82-1.27) 1.28 (0.5-3.29)
Adjusted for sex, age of FeNO measurement, asthma, reported allergies, parental smoking at the moment of the FeNO measurement, and parental education. Models including endotoxin, EPS and glucan
measurements were additionally adjusted for season of dust sampling. Models stratified by reported allergies were not adjusted for reported allergies. All the heterogeneity tests were not significant (p-values ≥ 0.05).
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to be inversely associated with allergic sensitization and
respiratory symptoms [18,19,50].
Asthma and atopy are known to be associated with
high FeNO in children [31,51,52]. Moreover, children
with persistent and late onset wheezing phenotypes are
more likely to show higher FeNO at school age [30] and
have higher risk of atopy and asthma [53,54]. FeNO is a
test that may be used to support the diagnosis of
asthma, and its role in asthma monitoring remains to be
defined [55]. The association between the biochemical
events involved in the release of NO in the airways and
the inflammatory mechanisms needs to be further stud-
ied [56], but, at present, FeNO is, a extensively studied
biomarker of airway inflammation and its non-invasive
nature makes it suitable for epidemiological studies
[27,44,55,57]. In line with the previous studies, FeNO in
our study was higher in asthmatic, allergic and atopic
children. We did not find differences in the associations
between endotoxin and dog exposures and FeNO ac-
cording to the report of asthma or allergy. However, the
additional adjustment for atopy resulted in a decrease in
the magnitude of the effect estimate of both exposures
on FeNO while the direction of the effect remained the
same. In addition, we considered the possibility that the
early life exposures evaluated in our study were associ-
ated with FeNO through an association with atopy and
not through airway inflammation. The statistical analyses
with atopy as outcome did not show significant associa-
tions between atopy and endotoxin concentrations or
early life dog ownership (data not shown).
However, caution is required when interpreting the re-
sults including information on atopy. Specific IgE levels
in blood were not available in 26% of our study popula-
tion and they were measured at different time points in
each cohort (at the age of the FeNO measurement in
LISA and PIAMA and at 4 years of age in INMA).
Our longitudinal study is the first epidemiologic study
assessing the long-term effects of early life exposure to
indoor microbial agents and related indoor factors on
FeNO measured at school age. Our study includes data
from subpopulations of three European birth cohorts in
three geographically spread locations and benefits from
the availability of objective measurements of exposure
during early life (2–3 months) and objective measure-
ments of airway inflammation at school age, in addition
to reported information periodically collected through
questionnaires administered from pregnancy or birth to
school age.
A few limitations must be considered when interpret-
ing our results. The study populations involved in the
HITEA project were selected differently depending on
the cohort. Only subsamples of LISA and PIAMA co-
horts were included in the project. Inclusion was basedon the availability of dust samples. In LISA, children in-
cluded in the present study never moved to another
home since early life. In PIAMA, the HITEA project in-
cludes children from the intervention study (high risk
children of allergic mothers). In addition, several differ-
ences existed between cohorts in subject characteristics
and dust sampling and analyses. In descriptive analyses
FeNO values and age were lowest in PIAMA, the cohort
with the highest number of allergic children. Results
from multivariable regression analyses showed that
FeNO, after age- and reported allergy adjustment, were
40% lower in INMA compared to PIAMA (GM ratio =
0.6; 95% CI: 0.4-0.9), and that FeNO in PIAMA children
was not different from that in LISA children (GM ratio = 0.9;
95% CI: 0.7-1.2). Regarding dust sampling and analyses,
INMA dust samples were taken from sofa instead of floor
because of the lack of carpets or rugs in the homes of the
Menorca island. Furthermore, INMA samples were ex-
tracted in borate buffered saline (BBS) for earlier analysis
of house dust mite allergens, which is not the standard ex-
traction fluid used for endotoxin analyses, additionally the
lack of heat-extraction impeded glucan quantification
from these samples.
Overall, the association estimates differed somewhat
by cohort. This might be explained by differences in in-
clusion criteria, in participants characteristics and in
dust sampling and analyses. For these reasons, we ex-
plored to what extent our results are driven by only one
or two cohorts by performing sensitivity analyses where
we excluded one cohort at a time from the meta-
analysis. The results from this sensitivity analyses
showed that the combined coefficients of endotoxin ex-
posure and for early life dog ownership are statistically
significant when excluding LISA from the meta-analyses
but not significant when excluding PIAMA or INMA.
Nevertheless, the magnitude and direction of the coeffi-
cients did not change. The number of individuals in-
cluded in the LISA cohort is lower than in the other
cohorts. Therefore, the lack of statistical significance in
the estimates when including LISA and only one of the
other participating cohorts may be related to the statis-
tical power and with the narrow range of exposures in
LISA. In addition, LISA homes were located in a high
density area (Munich city) while in the PIAMA and
INMA cohorts the density of the area where homes were
located varied. The density of the area where partici-
pants live may influence their behaviour regarding pet
ownership and the levels of indoor microbial agents.
This may also explain the differences observed in the co-
efficients for endotoxin exposure and dog ownership.
Apart from the differences across cohorts, other limi-
tations related with the associations between the expo-
sures, the outcome and the respiratory symptoms and
allergy should be considered. FeNO is associated with
Casas et al. Environmental Health 2013, 12:103 Page 9 of 11
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asthma and atopy may be associated with early life ex-
posure to microbial agents and related indoor factors
[5,6,15]. In order to assess the possibility of effect modi-
fication by reported allergy or atopy, we included inter-
action terms between the exposure variables in the
models and reported allergy and atopy. Associations for
the interaction terms between reported allergy or atopy
and endotoxin and dog ownership were not statistically
significant (p-values > 0.1). Moreover, stratified analyses
did not show differences in the effect estimates accord-
ing to the disease group. However, because of the limited
power after stratification, these results must be cau-
tiously interpreted.
Furthermore, dog ownership is associated with higher
levels of indoor endotoxins. In order to evaluate the inde-
pendent effects of these two indoor factors on FeNO, we
calculated the mutually adjusted coefficients for dog owner-
ship and endotoxin concentrations. These coefficients were
not different from those shown in Table 3. Therefore, we
may assume that the effects observed for the exposures to
endotoxin and dog ownership on FeNO are independent.
Finally, because the differences in FeNO across the dif-
ferent levels of exposure were small we must consider
the possibility that our findings are due to a statistical
association without a biological basis. Nevertheless, the
consistency between our findings with dog ownership
only in the first two years of life and endotoxin exposure
supports the biological basis of our findings.
Conclusions
Exposure to high concentrations of bacterial endotoxin
in the first months of life and dog ownership during the
first two years of life, but not exposure to fungal micro-
bial agents or home dampness, was associated with
lower FeNO at school age. Further studies are needed to
assess how this association is biologically explained, and
what the clinical relevance could be.
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